The effect of thrombospondin-1 and TGF-β1 on pancreatic cancer cell invasion

Daniel Albo, David H. Berger, George P. Tuszynski

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

We have previously shown that thrombospondin-1 (TSP-1) and TGF-β1 upregulate the urokinase plasminogen activator (uPA) and its receptor (uPAR) and promote tumor cell invasion in breast cancer. To date, the effect of TSP- 1 and TGF-β1 on the plasminogen/plasmin system in gastrointestinal epithelial malignancies has not been investigated. In this study, we determined the effect of TSP-1 and TGF-β1 on uPA and uPAR expression and on tumor cell invasion in pancreatic cancer. ASPC1 human pancreatic adenocarcinoma cells were incubated for 48 h on cell-conditioned media (CCM) either alone (Control) or with the addition of either TSP-1 (40 μg/ml) or TGF-β1 (5 ng/ml). uPA and uPAR expression were determined by ELISA, ASPC1 cell invasion was determined in a modified Boyden chamber type I collagen invasion assay. The upper chamber was treated with CCM either alone (Control) or with the addition of anti-uPA (10 μg/ml) or anti-uPAR (10 μg/ml). The lower chamber was treated with CCM either alone (Control) or with the addition of either TSP-1 (40 μg/ml) or TGF-β1 (5 ng/ml). TSP-1 and TGF-β1 induced a twofold increase on uPAR expression but only a slight increase on total uPA. Tumor cell invasion was upregulated 3.5 to 4.5-fold by TSP-1 and TGF-β1, respectively. Anti-uPA and anti-uPAR antibodies completely blocked the TSP-1 and TGF-β1-mediated pancreatic tumor cell invasion. We conclude that TSP-1 and TGF-β1 mediate pancreatic tumor cell invasion through upregulation of the plasminogen/plasmin system.

Original languageEnglish (US)
Pages (from-to)86-90
Number of pages5
JournalJournal of Surgical Research
Volume76
Issue number1
DOIs
StatePublished - Jan 1 1998
Externally publishedYes

Fingerprint

Thrombospondin 1
Pancreatic Neoplasms
Plasminogen Activators
Urokinase-Type Plasminogen Activator
Conditioned Culture Medium
Neoplasms
Plasminogen
Fibrinolysin
Up-Regulation
Urokinase Plasminogen Activator Receptors
Collagen Type I
Adenocarcinoma
Enzyme-Linked Immunosorbent Assay
Breast Neoplasms

Keywords

  • Pancreatic tumor cell invasion
  • Thrombospondin-1 (TSP-1)
  • Transforming growth factor Beta 1 (TGF- β1)
  • Urokinase plasminogen activator (uPA)
  • Urokinase plasminogen activator receptor (uPAR)

ASJC Scopus subject areas

  • Surgery

Cite this

The effect of thrombospondin-1 and TGF-β1 on pancreatic cancer cell invasion. / Albo, Daniel; Berger, David H.; Tuszynski, George P.

In: Journal of Surgical Research, Vol. 76, No. 1, 01.01.1998, p. 86-90.

Research output: Contribution to journalArticle

Albo, Daniel ; Berger, David H. ; Tuszynski, George P. / The effect of thrombospondin-1 and TGF-β1 on pancreatic cancer cell invasion. In: Journal of Surgical Research. 1998 ; Vol. 76, No. 1. pp. 86-90.
@article{8009fc13e4264bb9aa9444ba1382d430,
title = "The effect of thrombospondin-1 and TGF-β1 on pancreatic cancer cell invasion",
abstract = "We have previously shown that thrombospondin-1 (TSP-1) and TGF-β1 upregulate the urokinase plasminogen activator (uPA) and its receptor (uPAR) and promote tumor cell invasion in breast cancer. To date, the effect of TSP- 1 and TGF-β1 on the plasminogen/plasmin system in gastrointestinal epithelial malignancies has not been investigated. In this study, we determined the effect of TSP-1 and TGF-β1 on uPA and uPAR expression and on tumor cell invasion in pancreatic cancer. ASPC1 human pancreatic adenocarcinoma cells were incubated for 48 h on cell-conditioned media (CCM) either alone (Control) or with the addition of either TSP-1 (40 μg/ml) or TGF-β1 (5 ng/ml). uPA and uPAR expression were determined by ELISA, ASPC1 cell invasion was determined in a modified Boyden chamber type I collagen invasion assay. The upper chamber was treated with CCM either alone (Control) or with the addition of anti-uPA (10 μg/ml) or anti-uPAR (10 μg/ml). The lower chamber was treated with CCM either alone (Control) or with the addition of either TSP-1 (40 μg/ml) or TGF-β1 (5 ng/ml). TSP-1 and TGF-β1 induced a twofold increase on uPAR expression but only a slight increase on total uPA. Tumor cell invasion was upregulated 3.5 to 4.5-fold by TSP-1 and TGF-β1, respectively. Anti-uPA and anti-uPAR antibodies completely blocked the TSP-1 and TGF-β1-mediated pancreatic tumor cell invasion. We conclude that TSP-1 and TGF-β1 mediate pancreatic tumor cell invasion through upregulation of the plasminogen/plasmin system.",
keywords = "Pancreatic tumor cell invasion, Thrombospondin-1 (TSP-1), Transforming growth factor Beta 1 (TGF- β1), Urokinase plasminogen activator (uPA), Urokinase plasminogen activator receptor (uPAR)",
author = "Daniel Albo and Berger, {David H.} and Tuszynski, {George P.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1006/jsre.1998.5299",
language = "English (US)",
volume = "76",
pages = "86--90",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - The effect of thrombospondin-1 and TGF-β1 on pancreatic cancer cell invasion

AU - Albo, Daniel

AU - Berger, David H.

AU - Tuszynski, George P.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - We have previously shown that thrombospondin-1 (TSP-1) and TGF-β1 upregulate the urokinase plasminogen activator (uPA) and its receptor (uPAR) and promote tumor cell invasion in breast cancer. To date, the effect of TSP- 1 and TGF-β1 on the plasminogen/plasmin system in gastrointestinal epithelial malignancies has not been investigated. In this study, we determined the effect of TSP-1 and TGF-β1 on uPA and uPAR expression and on tumor cell invasion in pancreatic cancer. ASPC1 human pancreatic adenocarcinoma cells were incubated for 48 h on cell-conditioned media (CCM) either alone (Control) or with the addition of either TSP-1 (40 μg/ml) or TGF-β1 (5 ng/ml). uPA and uPAR expression were determined by ELISA, ASPC1 cell invasion was determined in a modified Boyden chamber type I collagen invasion assay. The upper chamber was treated with CCM either alone (Control) or with the addition of anti-uPA (10 μg/ml) or anti-uPAR (10 μg/ml). The lower chamber was treated with CCM either alone (Control) or with the addition of either TSP-1 (40 μg/ml) or TGF-β1 (5 ng/ml). TSP-1 and TGF-β1 induced a twofold increase on uPAR expression but only a slight increase on total uPA. Tumor cell invasion was upregulated 3.5 to 4.5-fold by TSP-1 and TGF-β1, respectively. Anti-uPA and anti-uPAR antibodies completely blocked the TSP-1 and TGF-β1-mediated pancreatic tumor cell invasion. We conclude that TSP-1 and TGF-β1 mediate pancreatic tumor cell invasion through upregulation of the plasminogen/plasmin system.

AB - We have previously shown that thrombospondin-1 (TSP-1) and TGF-β1 upregulate the urokinase plasminogen activator (uPA) and its receptor (uPAR) and promote tumor cell invasion in breast cancer. To date, the effect of TSP- 1 and TGF-β1 on the plasminogen/plasmin system in gastrointestinal epithelial malignancies has not been investigated. In this study, we determined the effect of TSP-1 and TGF-β1 on uPA and uPAR expression and on tumor cell invasion in pancreatic cancer. ASPC1 human pancreatic adenocarcinoma cells were incubated for 48 h on cell-conditioned media (CCM) either alone (Control) or with the addition of either TSP-1 (40 μg/ml) or TGF-β1 (5 ng/ml). uPA and uPAR expression were determined by ELISA, ASPC1 cell invasion was determined in a modified Boyden chamber type I collagen invasion assay. The upper chamber was treated with CCM either alone (Control) or with the addition of anti-uPA (10 μg/ml) or anti-uPAR (10 μg/ml). The lower chamber was treated with CCM either alone (Control) or with the addition of either TSP-1 (40 μg/ml) or TGF-β1 (5 ng/ml). TSP-1 and TGF-β1 induced a twofold increase on uPAR expression but only a slight increase on total uPA. Tumor cell invasion was upregulated 3.5 to 4.5-fold by TSP-1 and TGF-β1, respectively. Anti-uPA and anti-uPAR antibodies completely blocked the TSP-1 and TGF-β1-mediated pancreatic tumor cell invasion. We conclude that TSP-1 and TGF-β1 mediate pancreatic tumor cell invasion through upregulation of the plasminogen/plasmin system.

KW - Pancreatic tumor cell invasion

KW - Thrombospondin-1 (TSP-1)

KW - Transforming growth factor Beta 1 (TGF- β1)

KW - Urokinase plasminogen activator (uPA)

KW - Urokinase plasminogen activator receptor (uPAR)

UR - http://www.scopus.com/inward/record.url?scp=0031928751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031928751&partnerID=8YFLogxK

U2 - 10.1006/jsre.1998.5299

DO - 10.1006/jsre.1998.5299

M3 - Article

C2 - 9695745

AN - SCOPUS:0031928751

VL - 76

SP - 86

EP - 90

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -